- 商品介绍
- 规格参数
- 包装参数
Biochem/physiol Actions
Risedronate sodium is a bisphosphonate bone resorption inhibitor.
Risedronate sodium is a bisphosphonate bone resorption inhibitor. It has an affinity for hydroxyapatite crystals in bone and acts as an antiresorptive agent and is an inhibitor of farnesyl diphosphate (FPP) synthase, which results in downstream inhibition of osteoclast activity and reduced bone resorption and turnover. Risedronate sodium has been used to treat postmenopausal osteoporosis and Paget′s disease.
| Quality Segment | 100 |
| assay | ≥97% (HPLC) |
| form | powder |
| color | white to beige |
| solubility | H2O: 5 mg/mL, clear (warmed) |
| storage temp. | room temp |
| SMILES string | [Na+].[P](=O)([O-])(O)[C@]([P](=O)(O)O)(O)Cc1cnccc1 |
| InChI | 1S/C7H11NO7P2.Na/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6;/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15);/q;+1/p-1 |
| InChI key | DRFDPXKCEWYIAW-UHFFFAOYSA-M |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
询价
-
询价
-
询价
-
询价
-
询价
-
询价
-
询价
-
询价
-
询价
-
询价
-
询价
-
¥ 15214.65
-
询价
-
¥ 1196.00
-
¥ 8137.12
-
¥ 2869.87
-
¥ 1476.40
-
¥ 2099.27
-
¥ 2288.54
-
¥ 5990.26
微信小程序
7X24小时在线咨询